Lipid replacement therapy functional food formulation with NT factor for reducing weight, girth, body mass, appetite and fatigue while improving blood lipid profiles

Functional Foods in Health and Disease

Volumn 2, Issue 1, 2012, Pages 11-24

  Ellithorpe, Rita R ^a   Settineri, Robert ^b   Jacques, Brett ^a   Mitchell, Cyndee A ^a   Nicolson, Garth L ^c  

^a Tustin Longevity Center   (United States)

^b Sierra Productions Research LLC   (United States)

^c INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Alpha amylase inhibitor; Appetite; Blood lipoproteins; Body mass index; Fatigue; Girth; Hunger; Mitochondrial function; NT Factor ; Weight loss

Indexed keywords

EID: 84899437352     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v2i1.102     Document Type: Article

References (34)

1. Garaulet M, Ordovas JM, Madrid JA. The chronobiology, etiology and pathophysiology of obesity. Int J Obesity (London) 2010; 34: 1667-1683.
2. Farooqi IS. Genetic, molecular and physical insights into human obesity. Eur J Clin Invest 2011; 41: 451-455.
3. Ha TS, Tajar A, Lean ME. Obesity and weight management in the elderly. Br Med Bull 2011; 97: 169-196.
4. Buffenstein R, Karklin A, Driver HS. Beneficial physiological and performance responses to a month of restricted energy intake in healthy overweight women. Physiol Behav 2000; 68: 439-444.
5. Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-934.
6. Morrison JD. Fatigue as a presenting complaint in family practice. J Family Pract 1980; 10: 795-801.
7. Resnick HE, Carter EA, Alola M, Phillips B. Cross-sectional relationship of reported fatigue to obesity, diet, and physical activity: results from the third national health and nutrition examination survey. J Clin Sleep Med 2006; 2(2): 163-169.
8. Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, Chatman J. Medicare's search for effective obesity treatments: diets are not the answer. Am Psychol 2007; 62: 220-233.
9. Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nature Rev Endocrinol 2010; 6(10): 578-588.
10. Hensrud DD. Pharmacotherapy for obesity. Med Clin North Am 2000; 84: 463-476.
11. Yun JW. Possible anti-obesity therapeutics from nature. Phytochem 2010; 71: 1625-1641.
12. Han LK, Kimura Y, Okuda H. Anti-obesity effects of natural products. Stud Nat Prod Chem 2005; 30: 79-110.
13. Nicolson GL, Settineri R. Lipid Replacement Therapy: a functional food approach with new formulations for reducing cellular oxidative damage, cancer-associated fatigue and the adverse effects of cancer therapy. Funct Foods Health Dis 2011; 4: 135-160.
14. Layer P, Zinsmeister AR, de Magno EP. Effects of decreasing intraluninal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterol 1986; 91: 41-48.
15. Layer P, Rizza RA, Zinsmeister AR, et al. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc 1986; 61: 442-447.
16. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: A clinical trial using phase 2 brand proprietary fractionated white bean extract. Altern Med Rev 2004; 9(1): 63-69.
17. Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 2007; 4(1): 45-52.
18. Nicolson GL. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane oxidation and restore mitochondrial function. J Cell Biochem 2007; 100: 1352-1369.
19. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1,3,7-trimethulxanthine) in foods: a comprehensive review on consumption, functionality, safety and regulatory matters. J Food Sci 2010; 75: R77-R87.
20. Wang J, Li S, Fan Y, Chen Y, Liu D, Cheng H, Zhou Y. Anti-fatigue activity of the water - soluble polyscaccharides isolated from Panax ginseng C. A. Meyer. J Ethnopharmacol 2010; 30: 421-423.
21. Ellithorpe RR, Settineri R, Nicolson GL. Pilot study: reduction of fatigue by use of a dietary supplement containing glycophospholipids. J Am Nutraceut Assoc. 2003; 6(1): 23-28.
22. Piper BF, Dribble SL, Dodd MJ. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nursing Forum 1998; 25: 667-684.
23. Piper BF, Linsey AM, Dodd MJ. Fatigue mechanism in cancer. Oncol Nursing Forum 1987; 14: 17-23.
24. Arumugam V, Lee JS, Nowak JK, Pohle RJ, Nyrop JE, Leddy JJ, Pelkman CL. A high glycemic meal pattern elicited increased subjective appetite sensations in overweight and obese women. Appetite 2008; 50: 215-222.
25. Nicoson GL, Ellithorpe RR, Ayson-Mitchell C, Jacques B, Settineri R. Lipid Replacement Therapy with a glycophospholipid-antioxidant-vitamin formulation significantly reduces fatigue within one week. J Am Nutraceutical Assoc 2010; 13(1): 11-15.
26. MacKay NJ. Scaling of human body mass with height: the Body Mass Index revisited. J Biomechanics 2010; 43: 764-766.
27. Tundis R, Loizzo MR, Menichini F. Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem 2010; 10(4): 315-331.
28. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss ad glycemic control. Nutr J 2011; 10: 24.
29. Carai MA, Fantini N, Loi B, Colombo G, Riva A, Morazzoni P. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake and carbohydrate metabolism. Diabetes Metab Syndr Obes 2009; 2: 145-153.
30. Nicolson, G.L. and Ellithrope, R. Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses. J Chronic Fatigue Syndr. 2006; 13(1): 57-68.
31. Agadjanyan M, Vasilevko V, Ghochikyan A, Berns P, Kesslak P, Settineri R, Nicolson GL. Nutritional supplement (NTFactor) restores mitochondrial function and reduces moderately severe fatigue in aged subjects. J Chronic Fatigue Syndr 2003; 11(3): 23-26.
32. Blum K, Chen TJ, Meshkin B, Downs BW, Gordon CA, Blum S, Mengucci JF, Bravermn ER, arcuri V, Varshavskiy M, Deutsch R, Martinez-Pons M. Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant. Adv Ther 2006; 23(6): 1040-1051.
33. Blum K, Liu Y, Shriner R, Gold MS. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Curr Pharm Des 2011; 17(12): 1158-1167.
34. Chen AL, Blum K, Chen TJ, Giordano J, Downs BW, Han D Barh D, Braverman ER. Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report. Food Funct 2011; Nov. 3, 2011 [Epub ahead of print].